// App-Quantinova.ai

P053 : Circulating non-classical monocytes are reduced in patients with active IBD but increase after vedolizumab: a role for α4β7 in myeloid cell recruitment to the inflamed intestine

Researchers

Presenter

  • H. Gordon

Principal Investigators

  • I. Hoti

  • J.O. Lindsay

  • A. Stagg

Medical Centers

  • Royal London Hospital, Gastroenterology, London, United Kingdom

  • The Blizard Institute, Centre for Immunology, Barts and the London School of Medicine, London, UK

  • The Blizard Institute, Centre for Immunology, Barts and the London School of Medicine, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Human Leukocyte Antigen – DR isotype

Drug/Treatment

  • Entyvio

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A